Evidence map›Paper›PMID 32867051›Full record

ReviewMolecules (Basel, Switzerland)2020

Chiral Mesoporous Silica Materials: A Review on Synthetic Strategies and Applications.

Mingshu Cui, Wei Zhang, Luyao Xie, Lu Chen, Lu Xu

Open access · goldAbstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.0field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 20 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Cooperative formation of porous silica and peptides on the prebiotic Earth.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Mingshu CuiSchool of Pharmacy, Shenyang Pharmaceutical University, Shenyang 110016, China.
Wei ZhangSchool of Pharmacy, Shenyang Pharmaceutical University, Shenyang 110016, China.
Luyao XieSchool of Pharmacy, Shenyang Pharmaceutical University, Shenyang 110016, China.
Lu ChenSchool of Pharmacy, Shenyang Pharmaceutical University, Shenyang 110016, China.
Lu XuSchool of Pharmacy, Shenyang Pharmaceutical University, Shenyang 110016, China.ORCID 0000-0002-8739-692X
Shenyang Pharmaceutical University · CN

Funding

Career Development Support Plan in Shenyang Pharmaceutical University No. ZQN2018005Liaoning Provincial Natural Science Foundation 2019-MS-302
6 · The paper itself

Abstract

Because of its tunable textural properties and chirality feature, chiral mesoporous silica (CMS) gained significant consideration in many fields and has been developed rapidly in recent years. In this review, we provide an overview of synthesis strategies for fabricating CMS together with its main applications. The properties of CMS, including morphology and mesostructures and enantiomer excess (ee), can be altered according to the synthetic conditions during the synthesis process. Despite its primary stage, CMS has attracted extensive attention in many fields. In particular, CMS nanoparticles are widely used for enantioselective resolution and adsorption of chiral compounds with desirable separation capability. Also, CMS acts as a promising candidate for the effective delivery of chiral or achiral drugs to produce a chiral-responsive manner. Moreover, CMS also plays an important role in chromatographic separations and asymmetric catalysis. There has been an in-depth review of the synthetic methods and mechanisms of CMS. And this review aims to give a deep insight into the synthesis and application of CMS, especially in recent years, and highlights the significance that it may have in the future.

Indexed as

Antineoplastic AgentsCatalysisDrug Delivery SystemsNanoparticlesPhysical PhenomenaPorositySilicon DioxideStereoisomerismAntineoplastic AgentsSilicon Dioxideapplicationchiralitymesoporous silicasynthesis

Identifiers

PMID32867051
PMCPMC7504517
OpenAlexW3080853664

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.